40% of those infected with Covid-19 will develop long-term effects, declares study

According to researchers, it is not necessarily the most severe patients who suffer from the symptoms, but those who are mildly affected.

40% of people who overcome the covid develop sequelae that last more than six months, according to a study by a German university published Monday that claims shed light on covid syndrome persistent or “long covid”.

According to researchers from the Mainz University Clinic, are not necessarily the most seriously ill patients who develop these symptoms, but in many cases they affect asymptomatic people or who pass the disease with a mild course.

In 35% of the cases studied, the affected did not know even that they had passed COVID until they were subjected to an antibody test as part of the study, the researchers stressed in a university statement.

Some of the more common persistent symptoms are tiredness, memory disorders, joint pain, decreased taste and smell and respiratory difficulties, although there is no clear pattern and a unitary definition of the “long covid” has not yet been agreed upon.

The results published this Monday are part of a larger study with a sample of 10,250 people, of which about 500 had the disease, and suggest that the symptoms of persistent covid tend to disappear with the passage of time.

Cannabis extract reduces risk of catching COVID-19, study finds

To the surprise of the researchers, 46% of the women in the sample who contracted covid sand were affected, compared to 35% of men, despite the fact that the disease is usually more severe in men.

The age does not seem to increase the odds from contracting persistent covid, according to the study, which also revealed that a third of those infected claimed not to have recovered performance levels prior to the disease.

Poor air quality can aggravate COVID-19 cases, studies show

For 15%, the aftermath reaches the point to restrict your daily life, while in 6% of cases the former patients are limited in their work activity.

The university further announced that will launch a new study focused specifically on patients with persistent symptoms, with the aim of better defining the clinical picture.

In addition, they seek to identify risk factors, such as presence of certain biomarkers and find out what is the impact of the vaccine in the development of lasting sequelae.

Swedish Study Finds COVID-19 Vaccine Combination Effective

“Just a deep understanding of the mechanisms of action of the disease will allow an effective diagnosis and therapy, ”commented the spokesperson for the Directorate of Studies from the university, Philipp Wild. (I)

You may also like

Immediate Access Pro